YANKCOM Partnership Sells 627 Shares of Zoetis Inc. $ZTS

YANKCOM Partnership cut its holdings in Zoetis Inc. (NYSE:ZTS) by 22.5% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 2,165 shares of the company’s stock after selling 627 shares during the quarter. YANKCOM Partnership’s holdings in Zoetis were worth $338,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds also recently bought and sold shares of the business. Brighton Jones LLC grew its position in shares of Zoetis by 180.4% in the 4th quarter. Brighton Jones LLC now owns 4,629 shares of the company’s stock worth $754,000 after buying an additional 2,978 shares during the last quarter. PFG Advisors boosted its holdings in Zoetis by 28.9% in the first quarter. PFG Advisors now owns 9,627 shares of the company’s stock valued at $1,585,000 after acquiring an additional 2,157 shares in the last quarter. SYM FINANCIAL Corp purchased a new position in Zoetis during the 1st quarter valued at $217,000. Wedbush Securities Inc. increased its position in Zoetis by 91.0% during the 1st quarter. Wedbush Securities Inc. now owns 8,173 shares of the company’s stock valued at $1,346,000 after purchasing an additional 3,895 shares during the period. Finally, Pinnacle Associates Ltd. raised its holdings in Zoetis by 12.9% in the 1st quarter. Pinnacle Associates Ltd. now owns 21,435 shares of the company’s stock worth $3,529,000 after purchasing an additional 2,446 shares in the last quarter. Hedge funds and other institutional investors own 92.80% of the company’s stock.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently weighed in on ZTS shares. BTIG Research cut their target price on shares of Zoetis from $200.00 to $160.00 and set a “buy” rating on the stock in a research note on Wednesday, November 12th. Stifel Nicolaus cut their price objective on Zoetis from $140.00 to $130.00 and set a “hold” rating on the stock in a research report on Tuesday. Argus reissued a “buy” rating and issued a $190.00 target price on shares of Zoetis in a research report on Tuesday, September 9th. Weiss Ratings restated a “hold (c-)” rating on shares of Zoetis in a research note on Wednesday, October 8th. Finally, JPMorgan Chase & Co. reduced their price target on Zoetis from $230.00 to $200.00 and set an “overweight” rating on the stock in a research note on Wednesday, November 5th. Six investment analysts have rated the stock with a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat.com, Zoetis presently has a consensus rating of “Moderate Buy” and a consensus target price of $178.89.

Zoetis Stock Performance

NYSE ZTS opened at $115.86 on Friday. The firm has a market cap of $51.06 billion, a price-to-earnings ratio of 19.94, a price-to-earnings-growth ratio of 2.31 and a beta of 0.90. The company has a quick ratio of 1.04, a current ratio of 1.76 and a debt-to-equity ratio of 1.05. Zoetis Inc. has a twelve month low of $115.25 and a twelve month high of $181.85. The business has a 50-day moving average price of $138.28 and a 200-day moving average price of $150.42.

Zoetis (NYSE:ZTS) last issued its earnings results on Tuesday, November 4th. The company reported $1.70 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.62 by $0.08. Zoetis had a return on equity of 56.90% and a net margin of 27.83%.The firm had revenue of $2.40 billion for the quarter, compared to analysts’ expectations of $2.42 billion. During the same period in the previous year, the firm posted $1.58 earnings per share. The business’s revenue was up .5% compared to the same quarter last year. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. As a group, equities research analysts predict that Zoetis Inc. will post 6.07 EPS for the current fiscal year.

Zoetis Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 2nd. Shareholders of record on Friday, October 31st will be given a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 1.7%. The ex-dividend date is Friday, October 31st. Zoetis’s payout ratio is 33.67%.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.